Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Buffer Optimization Stabilizes RNA LNPs for Nebulized Lung D
2026-06-15
This study demonstrates that optimizing nebulization buffer composition can significantly stabilize RNA-loaded lipid nanoparticles (LNPs) for inhalable delivery. By fine-tuning buffer pH and excipient selection, the approach preserves nanoparticle size, RNA encapsulation, and bioactivity, addressing a core challenge in pulmonary RNA therapeutics.
-
ICG001: Wnt/β-Catenin Pathway Inhibitor in Translational Res
2026-06-15
ICG001 empowers researchers to dissect Wnt/β-catenin signaling with precision, enabling advanced modeling of cancer and fibrosis. This comprehensive guide outlines practical workflows, troubleshooting insights, and recent innovation, making ICG001 an essential tool for translational science.
-
CDC42 Polarity Regulates Intestinal Stem Cell Fate via YAP-m
2026-06-14
Zhang et al. uncover how CDC42-driven epithelial polarity orchestrates the balance between intestinal stem cells and transit amplifying cells through YAP-EGF-mTOR signaling, independently of Wnt pathways. These findings provide a mechanistic basis for epithelial homeostasis and open new avenues for gastrointestinal stem cell research.
-
Antiarrhythmic Drugs and KCa2 Channel Modulation in AF Resea
2026-06-13
This study systematically evaluates whether established antiarrhythmic agents, including Dronedarone (Multaq), directly inhibit small conductance calcium-activated potassium (KCa2) channels at concentrations relevant for atrial fibrillation (AF) treatment. Findings indicate that most clinically used drugs lack meaningful KCa2 channel inhibition, highlighting the need for new atrial-selective pharmacological strategies.
-
Autophagy Modulates Resveratrol-Induced Apoptosis in RCC Cel
2026-06-12
This study reveals that autophagy acts as a protective mechanism against resveratrol-induced apoptosis in renal cell carcinoma 786-O cells. By dissecting the roles of mitochondrial dysfunction, reactive oxygen species, and the caspase signaling pathway, the research highlights interplay between cell death and survival pathways, informing future cancer therapy strategies.
-
7-AAD Cell Viability Assay Kit: Precision in Apoptosis Detec
2026-06-12
The 7-AAD Cell Viability Assay Kit empowers researchers to accurately distinguish necrotic and late apoptotic cells in multiplexed cytometric workflows. By leveraging insights from CD38 CAR-T structural research, this assay offers unmatched spectral clarity and workflow versatility, making it a critical tool for advanced immunotherapy and cell engineering studies.
-
nor-NOHA Acetate: Redefining Arginase Inhibition for Tumor M
2026-06-11
Explore how nor-NOHA acetate enables precision modulation of arginine metabolism and immune regulation in cancer research. This article offers new insights by connecting arginase inhibition with immunometabolic pathways and practical assay design.
-
FITC-Concanavalin A (ConA) Conjugate: Technical Workflow Gui
2026-06-11
FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces, supporting precise workflows in immunofluorescence and flow cytometry. This product is not suitable for non-carbohydrate targets or for use outside its specified storage and stability limits.
-
Spiroplasma eriocheiris Entry in Drosophila S2 Cells: Cytosk
2026-06-10
This study demonstrates that Spiroplasma eriocheiris enters Drosophila S2 cells primarily via clathrin-mediated endocytosis and macropinocytosis, with infection strictly dependent on both actin and microtubule dynamics. The findings highlight new mechanistic insights into host-pathogen interactions in invertebrate models and inform design of assays targeting cytoskeletal pathways.
-
Isradipine (Dynacirc): Advancing Calcium Channel Selectivity
2026-06-10
Explore how Isradipine (Dynacirc) sets a new benchmark for selective L-type calcium channel inhibition in neurovascular research. This in-depth analysis reveals the unique scientific considerations, assay decisions, and translational impact of Isradipine, distinguishing its role from traditional pharmacological tools.
-
Nilotinib (AMN-107): Dissecting BCR-ABL Signaling and Riboto
2026-06-09
Explore how Nilotinib (AMN-107) advances chronic myeloid leukemia research by enabling precise BCR-ABL pathway analysis and illuminating the intersection with ribotoxic stress signaling. This article delivers new insights for experimental design beyond standard workflows.
-
MRE11:p.K464R Mutation Drives Olaparib Resistance in HGSOC
2026-06-09
Zhuang et al. identify the MRE11:p.K464R mutation as a novel molecular driver of resistance to the PARP inhibitor olaparib in high-grade serous ovarian cancer (HGSOC). Their study demonstrates how this mutation enhances DNA damage repair via increased interaction with RAD50 and RPS3, providing new insight into resistance mechanisms and potential biomarkers for therapy monitoring.
-
Autopalmitoylation of IDH1-R132H Links Lipid Metabolism to O
2026-06-08
This study uncovers a novel regulatory mechanism in which autopalmitoylation at C269 of mutant IDH1-R132H enhances its neomorphic activity, driving oncometabolite production and metabolic reprogramming in cancer cells. The findings highlight the intersection of lipid metabolism and epigenetic dysregulation in IDH1-mutant cancers, suggesting new therapeutic vulnerabilities.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Workf
2026-06-08
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) provides broad-spectrum protection against serine, cysteine, acid proteases, and aminopeptidases during protein extraction and analysis, without interfering with downstream applications sensitive to divalent cations. It is not suitable for workflows that require inhibition of metalloproteases via EDTA.
-
Parathyroid hormone (1-34) (human): New Insights into Valvul
2026-06-07
Explore how Parathyroid hormone (1-34) (human) advances bone metabolism and valvular calcification research through newly elucidated PTH-induced endothelial mechanisms. This article uncovers unique assay considerations and translational opportunities, providing foundational knowledge for innovative calcium regulation studies.